CD40·FasL inhibits human T cells: Evidence for an auto-inhibitory loop-back mechanism

International Immunology

Volumn 19, Issue 4, 2007, Pages 355-363

  Dranitzki Elhalel, M ^a   Huang, J H ^b   Sasson, M ^a   Rachmilewitz, J ^a   Parnas, M ^a   Tykocinski, M L ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CELL SURFACE RECEPTOR; CHIMERIC PROTEIN; FAS ANTIGEN; FAS LIGAND; HYBRID PROTEIN; CD3 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY;

APOPTOSIS; ARTICLE; CELL KILLING; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; CELL LINE; CELL STRAIN 3T3; COCULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD40; ANTIGENS, CD8; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CD40 LIGAND; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICE; NIH 3T3 CELLS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

EID: 34047094965     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm001     Document Type: Article

References (34)

1. Janeway, C. A. Jr and Bottomly, K. 1994. Signals and signs for lymphocyte responses. Cell 76:275.
2. Mueller, D. L., Jenkins, M. K. and Schwartz, K. H. 1989. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
3. Tykocinski, M. L., Kaplan, D. R. and Medof, M. E. 1996. Antigen-presenting cell engineering: The molecular toolbox. Am. J. Pathol. 148:1.
4. Kaplan, D. R., Hambor, J. E. and Tykocinski, M. L. 1989. An immunoregulatory function for the CD8 molecule. Proc. Natl Acad. Sci. USA 86:8512.
5. + CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 13:507.
6. Min, W. P., Gorczynski, R., Huang, X. Y. et al. 2000. Dendritic cells genetically engineered to express Fas ligand induce donorspecific hyporesponsiveness and prolong allograft survival. J. Immunol 164:161.
7. Matsue, H., Matsue, K., Walters, M., Okumura, K., Yagita, H. and Takashima, A. 1999. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected killer dendritic cells. Nat. Med 5:930.
8. Zhang, H. G., Su, X., Liu, D. et al. 1999. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J. Immunol. 162:1423.
9. Huang, J. H. and Tykocinski, M. L. 2001. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells. Int. Immunol 13:529.
10. Dranitzki Elhalel, M., Huang, J. H., Schmidt, W., Rachmilewitz, J. and Tykocinski, M. L. 2003. CTLA-4-FasL induces alloantigen-specific hyporesponsiveness. J. Immunol 170:5842.
11. Jin, Y., Qu, A., Wang, G. M., Hao, J., Gao, X. and Xie, S. 2004. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin. Gene Ther 11:982.
12. Schonbeck, U., Mach, F. and Libby, P. 2000. CD154 (CD40 ligand). Int. J. Biochem. Cell Biol. 32:687.
13. Graf, D., Korthauer, U., Mages, H. W., Senger, G. and Kroczek, R. A. 1992. Cloning of TRAP, a ligand for CD40 on human Tcells. Eur. J. Immunol. 22:3191.
14. Grammer, A. C., Bergman, M. C., Miura, Y., Fujita, K., Davis, L. S. and Lipsky, P. E. 1995. The CD40 ligand expressed by human T cells costimulates B cell responses. J. Immunol. 154:4996.
15. Spriggs, M. K., Armitage, R. J., Strockbine, L. et al. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med 176:1543.
16. + T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med 191:651.
17. Owenschaub, L. B., Yonehara, S., Crump, W. L. and Grimm, E. A. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 140:197.
18. O'flaherty, E., Ali, S., Pettit, S. J. and Kirby, J. A. 1998. Examination of the sensitivity of T cells to Fas ligation: Induction of allospecific apoptosis. Transplantation 66:1067.
19. Matzinger, P. 1991. The JAM test: A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185.
20. McLellan, A. D., Sorg, R. V., Williams, L. A. and Hart, D. N. 1996. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur. J. Immunol. 26:1204.
21. Holler, N., Tardivel, A., Kovacsovics-Bankowski, M. et al. 2003. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol. Cell Biol. 23:1428.
22. Brenner, B., Koppenhoefer, U., Grassme, H., Kun, J., Lang, F. and Gulbins, E. 1997. Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 417:301.
23. Grewal, I. S. and Flavell, R. A. 1996. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153:85.
24. Gaweco, A. S., Mitchell, B. L., Lucas, B. A., McClatchey, K. D. and Van Thiel, D. H. 1999. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection. Kidney Int. 55:1543.
25. 1 lupus-prone mice: Phenotype and possible role in autoreactivity. J. Immunol. 165:4095.
26. Yi, Y., McNerney, M. and Datta, S. K. 2000. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J. Immunol. 165:6627.
27. Jabara, H. H., Brodeur, S. R. and Geha, R. S. 2001. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J. Clin. Invest. 107:371.
28. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373:438.
29. Metkar, S. S., Manna, P. P., Anand, M., Naresh, K. N., Advani, S. H. and Nadkarni, J. J. 2001. CD40 ligand - an anti-apoptotic molecule in Hodgkin's disease. Cancer Biother. Radiopharm. 16:85.
30. Tai, Y. T., Catley, L. P., Mitsiades, C. S. et al. 2004. Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: Clinical implications. Cancer Res. 64:2846.
31. Haffar, O. K., Smithgall, M. D., Bradshaw, J., Brady, B., Damle, N. K. and Linsley, P. S. 1993. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. Proc. Natl Acad. Sci. USA 90:11094.
32. Kochli, C., Wendland, T., Frutig, K., Grunow, R., Merlin, S. and Pichler, W. J. 1999. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. Immunol. Lett. 65:197.
33. Weintraub, J. P. and Cohen, P. L. 1999. Ectopic expression of B7-1 (CD80) on T lymphocytes in autoimmune lpr and gld mice. Clin. Immunol. 91:302.
34. Zhu, D., Kepley, C. L., Zhang, M., Zhang, K. and Saxon, A. 2002. A novel human immunoglobulin Fcγ-Fc∈ bifunctional fusion protein inhibits Fc∈RI-mediated degranulation. Nat. Med. 8:518.